End-point | In vivo | In vitro | References |
---|---|---|---|
Cell morphology changes | Al2O3, TiO2 | Fe2O3, QDs | |
Increased inflammation signs and markers | MnO2 | Â | |
Increased oxidative stress | TiO2, QDs | Degussa P25, ferritin, C60, Ag | |
Antioxidative effects (inconsistent effects) | Â | CeO, YO, C60 | |
Neuron function (inhibition and facilitation) | MnO2, Zn, TiO2, QDs | Mn, Ag, ZnO, CuO, CNTs, TiO2, QDs | |
Behaviour (negative effect) | MnO2 | Â | [62] |
Development and differentiation (inconsistent effects) | TiO2 | Fe2O3, Ag, TiO2 | |
Accelerated protein fibrillation | Â | TiO2, CNT, QDs, CeO, copolymer particles |